-
1دورية أكاديمية
المؤلفون: Rasco, Drew W, Medina, Theresa, Corrie, Pippa, Pavlick, Anna C, Middleton, Mark R, Lorigan, Paul, Hebert, Chris, Plummer, Ruth, Larkin, James, Agarwala, Sanjiv S, Daud, Adil I, Qiu, Jiaheng, Bozon, Viviana, Kneissl, Michelle, Barry, Elly, Olszanski, Anthony J
المصدر: Cancer chemotherapy and pharmacology. 92(1)
مصطلحات موضوعية: Humans, Neoplasms, Melanoma, Skin Neoplasms, Neoplasms, Second Primary, Proto-Oncogene Proteins B-raf, Mitogen-Activated Protein Kinase Kinases, Protein Kinase Inhibitors, Maximum Tolerated Dose, Adult, BRAF, Pan-RAF inhibitor, Phase 1, Tovorafenib, Clinical Trials and Supportive Activities, Clinical Research, Cancer, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Pharmacology and Pharmaceutical Sciences, Oncology & Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/6jq463hgTest
-
2دورية أكاديمية
المؤلفون: Rasco, DW, Medina, T, Corrie, P, Pavlick, AC, Middleton, MR, Lorigan, P, Hebert, C, Plummer, R, Larkin, J, Agarwala, SS, Daud, AI, Qiu, J, Bozon, V, Kneissl, M, Barry, E, Olszanski, AJ
المساهمون: Larkin, James
مصطلحات موضوعية: BRAF, Melanoma, Pan-RAF inhibitor, Phase 1, Tovorafenib, Adult, Humans, Proto-Oncogene Proteins B-raf, Neoplasms, Skin Neoplasms, Protein Kinase Inhibitors, Second Primary, Mitogen-Activated Protein Kinase Kinases, Maximum Tolerated Dose
جغرافية الموضوع: Germany
وصف الملف: Print-Electronic; 28; application/pdf
العلاقة: Cancer Chemotherapy and Pharmacology, 2023, 92 (1), pp. 15 - 28; https://repository.icr.ac.uk/handle/internal/5936Test
الإتاحة: https://doi.org/10.1007/s00280-023-04544-5Test
https://repository.icr.ac.uk/handle/internal/5936Test -
3
المؤلفون: Drew W. Rasco, Theresa Medina, Pippa Corrie, Anna C. Pavlick, Mark R. Middleton, Paul Lorigan, Chris Hebert, Ruth Plummer, James Larkin, Sanjiv S. Agarwala, Adil I. Daud, Jiaheng Qiu, Viviana Bozon, Michelle Kneissl, Elly Barry, Anthony J. Olszanski
المساهمون: Barry, Elly [0000-0002-6890-2444], Apollo - University of Cambridge Repository
المصدر: Cancer chemotherapy and pharmacology, vol 92, iss 1
مصطلحات موضوعية: Adult, Proto-Oncogene Proteins B-raf, Cancer Research, Skin Neoplasms, Maximum Tolerated Dose, Clinical Trials and Supportive Activities, Phase 1, Toxicology, BRAF, Clinical Research, Neoplasms, Humans, Pharmacology (medical), Oncology & Carcinogenesis, Melanoma, Protein Kinase Inhibitors, Pan-RAF inhibitor, Cancer, Pharmacology, Mitogen-Activated Protein Kinase Kinases, Evaluation of treatments and therapeutic interventions, Neoplasms, Second Primary, Pharmacology and Pharmaceutical Sciences, Second Primary, Oncology, 6.1 Pharmaceuticals, Tovorafenib
وصف الملف: application/pdf; application/zip; text/xml
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6be879ecf897194f5e93f0a32cbcfa4dTest
https://www.repository.cam.ac.uk/handle/1810/350906Test -
4دورية أكاديمية
المؤلفون: Rasco, Drew W., Medina, Theresa, Corrie, Pippa, Pavlick, Anna C., Middleton, Mark R., Lorigan, Paul, Hebert, Chris, Plummer, Ruth, Larkin, James, Agarwala, Sanjiv S., Daud, Adil I., Qiu, Jiaheng, Bozon, Viviana, Kneissl, Michelle, Barry, Elly, Olszanski, Anthony J.
مصطلحات موضوعية: Phase 1, Pan-RAF inhibitor, Melanoma, BRAF, Tovorafenib
وصف الملف: application/pdf; application/zip; text/xml